Daniel T. Claiborne

1.3k total citations
27 papers, 439 citations indexed

About

Daniel T. Claiborne is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Daniel T. Claiborne has authored 27 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 15 papers in Immunology and 11 papers in Infectious Diseases. Recurrent topics in Daniel T. Claiborne's work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (11 papers) and HIV/AIDS drug development and treatment (9 papers). Daniel T. Claiborne is often cited by papers focused on HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (11 papers) and HIV/AIDS drug development and treatment (9 papers). Daniel T. Claiborne collaborates with scholars based in United States, United Kingdom and Germany. Daniel T. Claiborne's co-authors include Eric Hunter, Jessica Prince, Susan Allen, William Kilembe, Christian L. Boutwell, Zabrina L. Brumme, Vladimir Vrbanac, Todd M. Allen, Colby R. Maldini and Shangdong Liang and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Daniel T. Claiborne

23 papers receiving 433 citations

Peers

Daniel T. Claiborne
Sarah R. DiNapoli United States
Shuang Guo United States
Li Pan United States
Valerie Rezek United States
Gabriela L. Cosma United States
Miles Smith United States
Sarah R. DiNapoli United States
Daniel T. Claiborne
Citations per year, relative to Daniel T. Claiborne Daniel T. Claiborne (= 1×) peers Sarah R. DiNapoli

Countries citing papers authored by Daniel T. Claiborne

Since Specialization
Citations

This map shows the geographic impact of Daniel T. Claiborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel T. Claiborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel T. Claiborne more than expected).

Fields of papers citing papers by Daniel T. Claiborne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel T. Claiborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel T. Claiborne. The network helps show where Daniel T. Claiborne may publish in the future.

Co-authorship network of co-authors of Daniel T. Claiborne

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel T. Claiborne. A scholar is included among the top collaborators of Daniel T. Claiborne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel T. Claiborne. Daniel T. Claiborne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claiborne, Daniel T., Deborah Cromer, Youdiil Ophinni, et al.. (2025). High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection. Nature Communications. 16(1). 446–446. 3 indexed citations
2.
Miyamoto, Taito, Gauri Mirji, Alessio Ugolini, et al.. (2024). Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer. The Journal of Experimental Medicine. 221(12). 5 indexed citations
3.
Nie, Hao, Taito Miyamoto, Rafał Zieliński, et al.. (2024). Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade. Nature Communications. 15(1). 2853–2853. 17 indexed citations
4.
Maldini, Colby R., Faith Musenge, Frederick W. B. Li, et al.. (2024). Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells. Molecular Therapy. 32(10). 3485–3503. 6 indexed citations
5.
Parris, Joshua L.D., Gauri Mirji, Thibaut Barnoud, et al.. (2023). The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition. Cancer Research Communications. 3(7). 1200–1211. 3 indexed citations
6.
Miyamoto, Taito, Toshitha Kannan, Daniel T. Claiborne, et al.. (2023). 1101 Activation of myeloid cells suppresses metastatic ovarian cancer via tumoricidal neutrophils and IL-27-secreting macrophages. SHILAP Revista de lepidopterología. A1212–A1212.
7.
Miller, Katelyn D., Seamus O’Connor, Toshitha Kannan, et al.. (2023). Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. Nature Cancer. 4(10). 1491–1507. 78 indexed citations
8.
García-Beltrán, Wilfredo F., Daniel T. Claiborne, Colby R. Maldini, et al.. (2021). Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection. Frontiers in Immunology. 12. 667393–667393. 16 indexed citations
9.
Claiborne, Daniel T., Maud Déruaz, Carla Serra, et al.. (2021). Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8 + T cells and limit CD4 + T‐cell loss in BLT mice. European Journal of Immunology. 52(3). 447–461. 12 indexed citations
10.
Maldini, Colby R., Daniel T. Claiborne, Tao Chen, et al.. (2020). Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo. Nature Medicine. 26(11). 1776–1787. 76 indexed citations
11.
Brooks, Kelsie, Bradley R. Jones, Darío Dilernia, et al.. (2020). HIV-1 variants are archived throughout infection and persist in the reservoir. PLoS Pathogens. 16(6). e1008378–e1008378. 32 indexed citations
12.
Claiborne, Daniel T., Eileen P. Scully, Christine D. Palmer, et al.. (2019). Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis. PLoS Pathogens. 15(8). e1007981–e1007981. 5 indexed citations
13.
Ende, Zachary, Martin J. Deymier, Daniel T. Claiborne, et al.. (2018). HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs. Journal of Virology. 92(7). 8 indexed citations
14.
Collier, Dami A., Daniel T. Claiborne, Jessica Prince, et al.. (2016). Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency. Scientific Reports. 6(1). 38153–38153. 8 indexed citations
15.
Prince, Jessica, Daniel T. Claiborne, Luca Micci, et al.. (2014). HIV Replicative Capacity of Transmitted Viruses Is Associated with Early Immune Activation, Exhaustion and Establishment of the Viral Reservoir. AIDS Research and Human Retroviruses. 30(S1). A56–A57. 1 indexed citations
16.
Mónaco, Daniela C., Darío Dilernia, Kristine K. Dennis, et al.. (2014). Transmission of Pre-adapted Viruses Determines the Rate of CD4 Decline in Seroconverters from Zambia. AIDS Research and Human Retroviruses. 30(S1). A55–A56. 1 indexed citations
17.
Claiborne, Daniel T., Jessica Prince, & Eric Hunter. (2014). A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses. Journal of Visualized Experiments. 8 indexed citations
18.
Deymier, Martin J., Daniel T. Claiborne, Zachary Ende, et al.. (2014). Particle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloning. Virology. 468-470. 454–461. 20 indexed citations
19.
Naidoo, Vanessa, Zabrina L. Brumme, Jessica Prince, et al.. (2012). Impact of HLA-B*81-Associated Mutations in HIV-1 Gag on Viral Replication Capacity. Journal of Virology. 86(6). 3193–3199. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026